- Report
- October 2025
- 563 Pages
Global
From €5211EUR$5,850USD£4,534GBP
- Report
- July 2025
- 175 Pages
Global
From €3999EUR$4,490USD£3,480GBP
- Report
- March 2025
- 150 Pages
Global
From €3429EUR$3,850USD£2,984GBP
€4320EUR$4,850USD£3,759GBP
- Report
- November 2024
- 239 Pages
Global
From €3719EUR$4,175USD£3,236GBP
- Report
- September 2025
- 450 Pages
Global
From €4409EUR$4,950USD£3,837GBP
- Report
- October 2024
- 182 Pages
From €3158EUR$3,545USD£2,748GBP
€3509EUR$3,939USD£3,053GBP
- Report
- October 2024
- 195 Pages
From €3158EUR$3,545USD£2,748GBP
€3509EUR$3,939USD£3,053GBP
- Report
- June 2025
- 100 Pages
Global
From €5300EUR$5,950USD£4,612GBP
- Report
- October 2025
- 181 Pages
Global
From €3158EUR$3,545USD£2,748GBP
€3509EUR$3,939USD£3,053GBP
- Report
- October 2025
- 184 Pages
Global
From €3158EUR$3,545USD£2,748GBP
€3509EUR$3,939USD£3,053GBP
- Report
- October 2025
- 191 Pages
Global
From €3158EUR$3,545USD£2,748GBP
€3509EUR$3,939USD£3,053GBP
- Report
- October 2025
- 191 Pages
Global
From €3158EUR$3,545USD£2,748GBP
€3509EUR$3,939USD£3,053GBP
- Report
- October 2025
- 181 Pages
Global
From €3158EUR$3,545USD£2,748GBP
€3509EUR$3,939USD£3,053GBP
- Report
- October 2025
- 191 Pages
Global
From €3158EUR$3,545USD£2,748GBP
€3509EUR$3,939USD£3,053GBP
- Report
- October 2025
- 196 Pages
Global
From €3158EUR$3,545USD£2,748GBP
€3509EUR$3,939USD£3,053GBP
- Report
- October 2025
- 192 Pages
Global
From €3158EUR$3,545USD£2,748GBP
€3509EUR$3,939USD£3,053GBP
- Report
- October 2025
- 188 Pages
Global
From €3158EUR$3,545USD£2,748GBP
€3509EUR$3,939USD£3,053GBP
- Report
- August 2025
- 182 Pages
Global
From €3158EUR$3,545USD£2,748GBP
€3509EUR$3,939USD£3,053GBP
- Report
- August 2025
- 188 Pages
Global
From €3158EUR$3,545USD£2,748GBP
€3509EUR$3,939USD£3,053GBP
- Report
- August 2025
- 194 Pages
Global
From €3158EUR$3,545USD£2,748GBP
€3509EUR$3,939USD£3,053GBP

Live attenuated vaccines are a type of vaccine that use a weakened form of a virus or bacteria to stimulate an immune response. These vaccines are designed to replicate the natural infection process, allowing the body to develop immunity without the risk of serious illness. Live attenuated vaccines are typically administered orally or nasally, and are often used to protect against diseases such as measles, mumps, rubella, and rotavirus.
Live attenuated vaccines are generally considered to be safe and effective, and are often used in combination with other vaccines to provide broader protection. They are also cost-effective, as they require fewer doses than other types of vaccines.
Notable companies in the live attenuated vaccine market include Merck & Co., GlaxoSmithKline, Sanofi Pasteur, Pfizer, and Novartis. Show Less Read more